Clinical Pediatric Emergency Medicine
Volume 9, Issue 1 , Pages 4-16, March 2008

Management of Beta-Adrenergic Blocker Poisoning

  • Angela C. Anderson, MD, FAAP

      Affiliations

    • Corresponding Author InformationReprint requests and correspondence: Angela C. Anderson, MD, FAAP, Pediatric Emergency Medicine, Hasbro Children's Hospital, Providence, RI.

Pediatric Emergency Medicine, Hasbro Children's Hospital, Providence, RI 02903

Warren Alpert Medical School of Brown University, Providence, RI

Beta-adrenergic blocking agents or β-blockers are prescribed for the treatment of a broad array of common disorders. Their widespread use, coupled with a narrow therapeutic index, contributes to their being a significant cause of poisoning from overdose and the second most common cause of mortality from cardiovascular agents. This article provides an overview of beta-adrenergic system pathophysiology and the properties and pharmacokinetics of β-blockers. Also discussed are the various effects and management of β-blockers in overdose settings.

Keywords: β-blockers, poisoning, cardiovascular agents, overdose

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1522-8401(07)00098-5

doi:10.1016/j.cpem.2007.12.001

Clinical Pediatric Emergency Medicine
Volume 9, Issue 1 , Pages 4-16, March 2008